Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalOncotarget
Volume8
Issue number57
Pages (from-to)97516-97527
Number of pages12
ISSN1949-2553
DOIs
Publication statusPublished - 14 Nov 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • STAT3 mutation
  • Hsp90 and JAK inhibitors
  • high-throughput compound screening
  • hematological malignancy
  • GRANULAR LYMPHOCYTIC-LEUKEMIA
  • EPSTEIN-BARR-VIRUS
  • STAT3 MUTATIONS
  • SERINE PHOSPHORYLATION
  • MAXIMAL ACTIVATION
  • MCL-1 EXPRESSION
  • CELL LYMPHOMAS
  • SMALL-MOLECULE
  • INHIBITOR
  • TARGET
  • 3122 Cancers

Cite this